Meropenem resistance in Pseudomonas aeruginosa

Y Sumita1, M Fukasawa

  • 1Discovery Research Laboratories III, Sumitomo Pharmaceuticals, Osaka, Japan.

Chemotherapy
|January 1, 1996
PubMed

Insights

Two Pseudomonas aeruginosa genes, mpmA and mpmB, confer low susceptibility to meropenem by reducing antibiotic permeability. This discovery suggests novel meropenem translocation pathways beyond OprD2.

Area of Science:

  • Microbiology
  • Genetics
  • Pharmacology

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen known for its intrinsic and acquired resistance to antibiotics.
  • Meropenem is a critical carbapenem antibiotic used to treat serious infections caused by Gram-negative bacteria.
  • Understanding the mechanisms of meropenem resistance is crucial for developing effective treatment strategies.

Purpose of the Study:

  • To identify and characterize the genetic basis of spontaneous meropenem resistance in Pseudomonas aeruginosa.
  • To elucidate the specific mutations and their impact on antibiotic susceptibility and outer membrane protein expression.
  • To investigate potential novel pathways for meropenem translocation across the bacterial outer membrane.

Main Methods:

  • Isolation and characterization of meropenem-low-susceptibility Pseudomonas aeruginosa PAO2152 mutants.
  • Genetic mapping of resistance genes (mpmA and mpmB) on the bacterial chromosome.
  • Analysis of outer membrane protein profiles, beta-lactamase activity, and penicillin-binding protein affinities.
  • Transductional analysis to determine the allelic relationship of resistance genes.

Main Results:

  • Two distinct classes of meropenem-resistant mutants were identified, linked to mpmA and mpmB genes.
  • mpmA mutation was associated with the loss of outer membrane protein D2 (OprD2), conferring cross-resistance to carbapenems.
  • mpmB mutation increased meropenem resistance 4-fold, with cross-resistance to other agents but susceptibility to imipenem, and was linked to nalB/cfxB/oprK.
  • Both mutations appeared to reduce antibiotic permeability through the outer membrane, suggesting alternative meropenem translocation routes.

Conclusions:

  • Meropenem resistance in P. aeruginosa can arise from mutations in mpmA (linked to OprD2) and mpmB (an allele of nalB/cfxB/oprK).
  • These mutations likely reduce antibiotic permeability, indicating potential novel translocation pathways for meropenem independent of OprD2.
  • Meropenem exhibits significantly higher activity than imipenem against OprD2-deficient P. aeruginosa strains.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...